Joseph Clark
Affiliations: | University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA, United States |
Google:
"Joseph Clark"Mean distance: (not calculated yet)
Parents
Sign in to add mentor
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Pereira JA, Lanzar Z, Clark JT, et al. (2023) PD-1 and CTLA-4 exert additive control of effector regulatory T cells at homeostasis. Frontiers in Immunology. 14: 997376 |
| Clark JT, Weizman OE, Aldridge DL, et al. (2023) IL-18BP mediates the balance between protective and pathological immune responses to Toxoplasma gondii. Cell Reports. 42: 112147 |
| Christian DA, Adams TA, Shallberg LA, et al. (2022) cDC1 coordinate innate and adaptive responses in the omentum required for T cell priming and memory. Science Immunology. 7: eabq7432 |
| Perry JA, Shallberg L, Clark JT, et al. (2022) PD-L1-PD-1 interactions limit effector regulatory T cell populations at homeostasis and during infection. Nature Immunology |
| Dumaine JE, Sateriale A, Gibson AR, et al. (2021) The enteric pathogen exports proteins into the cytosol of the infected host cell. Elife. 10 |
| Clark JT, Christian DA, Gullicksrud JA, et al. (2021) IL-33 promotes innate lymphoid cell-dependent IFN-γ production required for innate immunity to . Elife. 10 |
| Moore TV, Scurti GM, DeJong M, et al. (2021) HDAC inhibition prevents transgene expression downregulation and loss-of-function in T-cell-receptor-transduced T cells. Molecular Therapy Oncolytics. 20: 352-363 |
| Chen L, Christian DA, Kochanowsky JA, et al. (2020) The Toxoplasma gondii virulence factor ROP16 acts in cis and trans, and suppresses T cell responses. The Journal of Experimental Medicine. 217 |
| Moore T, Wagner CR, Scurti GM, et al. (2017) Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells. Cancer Immunology, Immunotherapy : Cii |
| Klarquist J, Tobin K, Farhangi Oskuei P, et al. (2016) CCL22 DIVERTS T REGULATORY CELLS AND CONTROLS THE GROWTH OF MELANOMA. Cancer Research |